Nu-Med Plus NUMD
OTC NUMD
$0.01 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nu-Med Plus (NUMD) Gains from Sales and Divestitures (2022)

Updated

Analysis

Nu-Med Plus (NUMD) Gains from Sales and Divestitures (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 248.23 Bn 227.26 Bn 4.88 Bn
2 Abbott Laboratories 178.27 Bn 148.70 Bn 7.27 Bn
3 Danaher 159.74 Bn 143.55 Bn 3.61 Bn
4 Intuitive Surgical 158.43 Bn 138.72 Bn 2.08 Bn
5 Medtronic 122.58 Bn 87.83 Bn 6.34 Bn
6 Stryker 118.22 Bn 104.33 Bn 4.50 Bn
7 Boston Scientific 66.78 Bn 61.54 Bn 3.85 Bn
8 Becton Dickinson 54.39 Bn 51.54 Bn 2.32 Bn
9 Edwards Lifesciences 51.62 Bn 35.63 Bn 1.35 Bn
10 Nu-Med Plus 835,484.67 826,603.67 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -3,000.00
API Access

Nu-Med Plus Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NUMD&period=max&api_key=YOUR_API_KEY